Bridgewater Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
Bridgewater Associates's CELG Position: Q1 2019 in Review
Bridgewater Associates sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 878,145 shares — an estimated $56.3M sold.
Bridgewater Associates first reported a position in CELG in Q4 2013 and held it in 14 quarters. The position peaked at $56.3M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- Bridgewater Associates reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- Bridgewater Associates sold 878,145 Celgene Corp shares in Q1 2019, an estimated $56.3M.
- Bridgewater Associates first reported a position in Celgene Corp in Q4 2013 and held it in 14 quarters.
- Bridgewater Associates's Celgene Corp position peaked at $56.3M in Q4 2018.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on Bridgewater Associates's 13F filing for Q1 2019, filed 14 May 2019.